Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: Prediction of outcome

Psychiatry Research

Volumn 105, Issue 1-2, 2001, Pages 107-115

  Chanpattana, Worrawat ^a   Somchai Chakrabhand, M L ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b Ministry of Health   (Thailand)

Author keywords

Electroconvulsive therapy (ECT); Nature of clinical response; Negative symptoms; Predictive factors of response; Schizophrenia

Indexed keywords

FLUPENTIXOL; NEUROLEPTIC AGENT;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROCONVULSIVE THERAPY; FAMILY HISTORY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; NEGATIVE SYNDROME; PREDICTION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; ELECTROCONVULSIVE THERAPY; FEMALE; FLUPENTHIXOL; HUMANS; MALE; MENTAL STATUS SCHEDULE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0035894087     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00321-3     Document Type: Conference Paper

References (44)

1. The practice of ECT in India: Issues relating to the administration of ECT
2. Elektrokonvulsivni lecba v Ceske republice v letech 1981-1989
3. Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration
4. Neuroleptic responsivity of negative and positive symptoms in schizophrenia
5. Un neuvo metodo di shockterapie 'L'elettro-shock'
6. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia
7. Continuation ECT in treatment-resistant schizophrenia: A controlled study
8. The use of stabilization period in ECT research in schizophrenia: II. Implementation
9. Electroconvulsive therapy in the treatment-resistant patient
10. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms
11. Definition and epidemiology of treatment-resistant depression
12. The effect of sequential antidepressant treatment on geriatric depression
13. Cognitive deficits in schizophrenia
14. Negative and deficit symptoms in schizophrenia do respond to neuroleptics
15. Drug resistant depression: Response to ECT
16. Prognostic variables for electro-shock therapy
17. Cerebral ventricular size and cognitive impairment in chronic schizophrenia
18. Results with electric convulsive therapy in 200 cases of schizophrenia
19. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
20. Pharmacologic treatment of schizophrenia
21. Assessment of the differences in MMSE between neurological, psychiatric patients and normal population
22. Electroconvulsive therapy and schizophrenia
23. Electroconvulsive therapy in the Republic of Ireland 1982: A summary of findings
24. Trial of maintenance therapy in schizophrenia
25. Schizophrenic syndromes, cognitive performance, and neurological dysfunction
26. An epidemiological study of electroconvulsive therapy: Rate and diagnosis
27. Clinical trial of the depressive illnesss
28. The brief psychiatric rating scale
29. Medication resistance and clinical response to electroconvulsive therapy
30. Anticonvulsant and antidepressant properties of electroconvulsive therapy: A proposed mechanism of action
31. Seizure threshold in electroconvulsive therapy: Effects of sex, age, electrode placement, and number of treatments
32. Studies of dosage, seizure threshold, and seizure duration in ECT
33. Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy
34. ECT for schizophrenia
35. Use of ECT in the United States in 1975 and 1980
36. Use of ECT in the United States in 1975, 1980, and 1986
37. Cognitive function in schizophrenic patients
38. Risperidone in treatment-refractory schizophrenia